Seth Banever

Seth Banever practices at The Bradley Home in Newington, Connecticut.

Seth Banever's NPI, 1013302264, was assigned on April 4, 2015. Seth Banever holds Connecticut license 629921.

Seth Banever's primary practice is The Bradley Home, at 151 Rockwell Rd, Newington, CT 06111 in Capitol County. The practice phone is (203) 235-5716.

Seth Banever's primary practice is The Bradley Home in Newington, Connecticut. The medical group on file is Connecticut Valley Hospital. Dmand AI also links Seth Banever to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Seth Banever practices, 3 sites in all. Vendor and product names are available with a free account.

Psychiatry is Seth Banever's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Seth Banever is licensed in Connecticut.

CMS data shows 2,577 Medicare services from Seth Banever across 8 procedure codes in 2024, for 428 Medicare patients. Medicare paid $185,226 for them. Every service was in an office.

CMS counts 428 Medicare patients who saw Seth Banever in 2024. The largest group is 85 and over, with 221 patients. 75% of them have high blood pressure, and 75% have mood disorders. 64% are also on Medicaid. Their average risk score is 2.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

In 2024, Seth Banever wrote 1,056 Medicare Part D claims for 179 patients. 99% of them were for generic drugs. CMS names the drug for 972 of them, across 20 drugs with 11 or more claims each, at $18,855 in total drug cost. In 2023, CMS named 1,115 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 47 out of 100 for Seth Banever for performance year 2024, reported through an alternative payment model (APM). Seth Banever accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Seth Banever from 1 drug or device company in 2022. Food and beverage make up the largest share, 100% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $117.